Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)
China · Delayed Price · Currency is CNY 4.130
+0.090 (2.23%)
Jun 2, 2026, 3:05 PM CST
SHE:002198 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 27.53 | 30.48 | 20.61 | 34.32 | 43.93 | 1.48 |
Depreciation & Amortization | 21.29 | 21.29 | 19.55 | 24.21 | 25.89 | 28.4 |
Other Amortization | 2.06 | 2.06 | 0.16 | - | - | - |
Loss (Gain) From Sale of Assets | 0.13 | 0.13 | -1.61 | -0.14 | 0.01 | - |
Asset Writedown & Restructuring Costs | 3.81 | 3.81 | 0.26 | 0.05 | 2.58 | 0.19 |
Loss (Gain) From Sale of Investments | 1.51 | 1.51 | -0.68 | -1.11 | -0.67 | 27.68 |
Provision & Write-off of Bad Debts | - | - | 4.05 | -0.65 | 2.66 | -2 |
Other Operating Activities | -21.61 | -0.1 | 1.18 | 0.78 | 1.11 | 0.84 |
Change in Accounts Receivable | -111.58 | -111.58 | 32.22 | 118.37 | -86.45 | 9.62 |
Change in Inventory | 6.72 | 6.72 | 0.36 | -2.36 | -8.41 | -0.78 |
Change in Accounts Payable | 55.46 | 55.46 | -14.33 | -75.13 | 44.11 | -14.65 |
Operating Cash Flow | -15.45 | 9 | 60.85 | 98.45 | 27.15 | 51.8 |
Operating Cash Flow Growth | - | -85.21% | -38.20% | 262.57% | -47.58% | -46.53% |
Capital Expenditures | -109.66 | -109.92 | -38.7 | -5.06 | -2.74 | -2.34 |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0.89 | 1.45 | 0.09 | 0.01 |
Divestitures | -1.44 | - | - | - | - | - |
Investment in Securities | -28.61 | -32.38 | - | - | - | 32.5 |
Other Investing Activities | 5.58 | 2.15 | 205 | -146.63 | -48.38 | 25.04 |
Investing Cash Flow | -134.11 | -140.14 | 167.18 | -150.24 | -51.03 | 55.21 |
Short-Term Debt Issued | - | - | - | - | - | 31.11 |
Total Debt Issued | 20 | - | - | - | - | 31.11 |
Short-Term Debt Repaid | - | - | - | - | - | -15 |
Long-Term Debt Repaid | - | - | - | - | -31.11 | - |
Total Debt Repaid | - | - | - | - | -31.11 | -15 |
Net Debt Issued (Repaid) | 20 | - | - | - | -31.11 | 16.11 |
Common Dividends Paid | - | - | -25.4 | - | - | - |
Other Financing Activities | 11.75 | -38.25 | - | -0 | -0.45 | -1.02 |
Financing Cash Flow | 31.75 | -38.25 | -25.4 | -0 | -31.56 | 15.09 |
Foreign Exchange Rate Adjustments | -1.48 | -1.48 | - | - | - | - |
Net Cash Flow | -119.3 | -170.87 | 202.63 | -51.79 | -55.44 | 122.1 |
Free Cash Flow | -125.12 | -100.92 | 22.14 | 93.39 | 24.41 | 49.46 |
Free Cash Flow Growth | - | - | -76.29% | 282.53% | -50.63% | -41.95% |
Free Cash Flow Margin | -32.50% | -26.30% | 5.89% | 17.51% | 3.70% | 8.61% |
Free Cash Flow Per Share | -0.23 | -0.20 | 0.04 | 0.18 | 0.05 | 0.10 |
Cash Interest Paid | - | - | 0 | 0 | 0.45 | 1.02 |
Cash Income Tax Paid | 51.52 | 47.22 | 45.55 | 72.08 | 73.23 | 75.35 |
Levered Free Cash Flow | -136.63 | -115.78 | 16.77 | 84.77 | 5.75 | 73.89 |
Unlevered Free Cash Flow | -136.63 | -115.78 | 16.78 | 84.77 | 6.04 | 74.53 |
Change in Working Capital | -50.18 | -50.18 | 17.33 | 40.99 | -48.37 | -4.78 |